lobbying_activities: 1661469

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1661469	e1ee4242-67a7-4a55-bb8c-71e41c2cc99d	Q1	GSK (FKA GLAXOSMITHKLINE INC.)	16293	GSK (FKA GLAXOSMITHKLINE INC.)	2015	first_quarter	TAR	No bill # assigned - issues related to the temporary duty suspension for preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking (provided for in subheading 2106.90.99)	HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)		1730000	0	0	2015-04-15T10:45:31.960000-04:00